Gerresheimer AG (FRA:GXI)
43.24
-0.38 (-0.87%)
Last updated: Aug 1, 2025
Blueprint Medicines Market Cap
Gerresheimer AG has a market cap or net worth of €1.45 billion as of August 1, 2025. Its market cap has decreased by -56.11% in one year.
Market Cap
1.45B
Enterprise Value
3.62B
Revenue
2.19B
Ranking
n/a
PE Ratio
22.93
Stock Price
$43.24
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has increased from 1.20B to 1.45B, an increase of 20.47%. That is a compound annual growth rate of 1.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 1.50B | -38.90% |
Dec 30, 2024 | 2.45B | -24.75% |
Dec 29, 2023 | 3.26B | 65.26% |
Dec 30, 2022 | 1.97B | -25.86% |
Dec 30, 2021 | 2.66B | -3.48% |
Dec 30, 2020 | 2.76B | 27.17% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 292.08B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 153.20B |
Allianz SE | 132.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 79.52B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
Deutsche Bank Aktiengesellschaft | 55.70B |